CLSI M48 P : 1ED 2007

Abstract
Committee Membership
Foreword
1 Scope
2 Safety and Standard Precautions
  2.1 Risk Assessment
  2.2 Biosafety Levels-General
  2.3 Additional Aspects of Biosafety Pertinent to
      Mycobacteriology
3 Levels of Laboratory and Referral Services
4 Clinical Significance of Mycobacterium spp
  4.1 Clinical Setting/Pathogenicity
  4.2 Laboratory Indicators
5 Specimen Types, Collection, Transport, and Storage
6 Specimen Processing
7 Detection of Mycobacteria
  7.1 Microscopy
  7.2 Nucleic Acid Amplification Tests (NAATs) For Direct
      Detection of M. tuberculosis Complex in Clinical Specimens
  7.3 Detection of Mycobacteria by Culture
8 Identification Procedures
  8.1 Phenotypic Methods
  8.2 Genotypic Methods
References
Appendix A. Final Rule, Department of Transportation Pipeline
            and Hazardous Materials Safety Administration,
            Hazardous Materials: Infectious Substances;
            Harmonization With the United Nations Recommendations,
            June 7, 2006
Appendix B. Methods for Digestion and Decontamination
Appendix C. Staining Procedures
Appendix D. Preparation and Storage of Quality Control Organisms
Appendix E. Biochemical Procedures
The Quality System Approach
Related CLSI/NCCLS Publications

Provides guidance to clinical mycobacteriology laboratories on the most optimum approach for the diagnosis of mycobacterial infections.